Loading company
Kairos Pharma, LTD.
KAPA · NYSE · ·
$1.68-1.2%Sep 29 close
- 1M
- +1.2%
- 6M
- -56.4%
- 1Y
- -79.5%
KAPA · NYSE · ·
$1.68-1.2%Sep 29 close
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Profit | -$1.4M | -$1.4M | +2.39% |
| Profit per share | -$0.06 | -$0.08 | +25.00% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Kairos Pharma, LTD. has no earnings call transcript available.